Hennink WE - Search Results

1

E-selectin targeted immunoliposomes for rapamycin delivery to activated endothelial cells.

Gholizadeh S, Visweswaran GRR, Storm G, Hennink WE, Kamps JAAM, Kok RJ. Gholizadeh S, et al. Among authors: hennink we. Int J Pharm. 2018 Sep 15;548(2):759-770. doi: 10.1016/j.ijpharm.2017.10.027. Epub 2017 Oct 13. Int J Pharm. 2018. PMID: 29038064 Free article.

2

Stabilization of polymer-based gene delivery systems.

Cherng JY, vd Wetering P, Talsma H, Crommelin DJ, Hennink WE. Cherng JY, et al. Among authors: hennink we. Int J Pharm. 1999 Jun 10;183(1):25-8. doi: 10.1016/s0378-5173(99)00037-x. Int J Pharm. 1999. PMID: 10361148

3

Comparative transfection studies of human ovarian carcinoma cells in vitro, ex vivo and in vivo with poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes.

van de Wetering P, Schuurmans-Nieuwenbroek NM, Hennink WE, Storm G. van de Wetering P, et al. Among authors: hennink we. J Gene Med. 1999 May-Jun;1(3):156-65. doi: 10.1002/(SICI)1521-2254(199905/06)1:3<156::AID-JGM29>3.0.CO;2-O. J Gene Med. 1999. PMID: 10738564

4

Cationic polymeric gene delivery of beta-glucuronidase for doxorubicin prodrug therapy.

Fonseca MJ, Storm G, Hennink WE, Gerritsen WR, Haisma HJ. Fonseca MJ, et al. Among authors: hennink we. J Gene Med. 1999 Nov-Dec;1(6):407-14. doi: 10.1002/(SICI)1521-2254(199911/12)1:6<407::AID-JGM71>3.0.CO;2-Q. J Gene Med. 1999. PMID: 10753066

5

Effects of physicochemical characteristics of poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes on cellular association and internalization.

Zuidam NJ, Posthuma G, de Vries ET, Crommelin DJ, Hennink WE, Storm G. Zuidam NJ, et al. Among authors: hennink we. J Drug Target. 2000;8(1):51-66. doi: 10.3109/10611860009009209. J Drug Target. 2000. PMID: 10761645

6

Degradable dextran microspheres for the controlled release of liposomes.

Stenekes RJ, Loebis AE, Fernandes CM, Crommelin DJ, Hennink WE. Stenekes RJ, et al. Among authors: hennink we. Int J Pharm. 2001 Feb 19;214(1-2):17-20. doi: 10.1016/s0378-5173(00)00625-6. Int J Pharm. 2001. PMID: 11282230

7

The fate of poly(2-dimethyl amino ethyl)methacrylate-based polyplexes after intravenous administration.

Verbaan FJ, Oussoren C, van Dam IM, Takakura Y, Hashida M, Crommelin DJ, Hennink WE, Storm G. Verbaan FJ, et al. Among authors: hennink we. Int J Pharm. 2001 Feb 19;214(1-2):99-101. doi: 10.1016/s0378-5173(00)00642-6. Int J Pharm. 2001. PMID: 11282245

8

Lipid-coated polyplexes for targeted gene delivery to ovarian carcinoma cells.

Mastrobattista E, Kapel RH, Eggenhuisen MH, Roholl PJ, Crommelin DJ, Hennink WE, Storm G. Mastrobattista E, et al. Among authors: hennink we. Cancer Gene Ther. 2001 Jun;8(6):405-13. doi: 10.1038/sj.cgt.7700311. Cancer Gene Ther. 2001. PMID: 11498760

9

Nanotechnological approaches for the delivery of macromolecules.

Crommelin DJ, Storm G, Jiskoot W, Stenekes R, Mastrobattista E, Hennink WE. Crommelin DJ, et al. Among authors: hennink we. J Control Release. 2003 Feb 21;87(1-3):81-8. doi: 10.1016/s0168-3659(03)00014-2. J Control Release. 2003. PMID: 12618025 Review.

10

Preparation and characterization of folate-targeted pEG-coated pDMAEMA-based polyplexes.

van Steenis JH, van Maarseveen EM, Verbaan FJ, Verrijk R, Crommelin DJ, Storm G, Hennink WE. van Steenis JH, et al. Among authors: hennink we. J Control Release. 2003 Feb 21;87(1-3):167-76. doi: 10.1016/s0168-3659(02)00361-9. J Control Release. 2003. PMID: 12618033

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

567 results

Search Page